Supply of Cardiovascular Angiographic Catheters

The contract requires the manufacture and supply of sterile, latex-free cardiovascular catheters designed for angiographic procedures, featuring a high-torque shaft for precise maneuverability, radiopaque properties to ensure clear visualization under fluoroscopy, and full compatibility with 0.038-inch guidewires. All delivered products must include compliant packaging and labeling that meet regulatory and operational standards, ensuring traceability and safety throughout the supply chain. The scope encompasses end-to-end fulfillment from production through final delivery, with strict adherence to quality and sterility protocols to support clinical use in medical settings. This subcontract is issued under the NAICS code 339112 and is managed by the Department of Defense’s Medical Supply Chain MD Surg FSF, with the solicitation posted on August 5, 2026, and responses due by August 11, 2026. The place of performance and point of contact details are unspecified, but the contract will be administered through the DLA’s DIBBS platform. There is no set-aside designation specified, meaning the opportunity is open to all eligible suppliers without preference for small businesses or other categories. Proposals must demonstrate technical capability to meet all product specifications and delivery requirements within the tight solicitation window.